Consensus Position Statement - Rh(D) Immunoglobulin and Women with High Body Mass Index
A recent update of the Rh(D) Immunoglobulin-VF Product Information by CSL Behring has generated questions from healthcare professionals regarding the implications of this change on clinical and laboratory practice. To support the healthcare community, an expert panel was convened by the Australian Red Cross Lifeblood and the National Blood Authority. A record of the meeting and updated frequently asked questions about the use of Rh(D) Immunoglobulin have been prepared.
Rhd Support Material